During the past decade, The Angeles Clinic and Research Institute - W LA Office conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 10 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Angeles Clinic and Research Institute - W LA Office" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Genentech, Inc." with 5 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Attenuon" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Angeles Clinic and Research Institute - W LA Office" #1 collaborator was "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "The Angeles Clinic and Research Institute - W LA Office" are "Malignant Melanoma" (4 trials), "Melanoma" (4 trials), "Advanced Solid Tumors" (2 trials), "Bladder Cancer" (2 trials) and "Non-Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "The Angeles Clinic and Research Institute - W LA Office" in a lesser frequency.

Most popular intervention types in "The Angeles Clinic and Research Institute - W LA Office" are "Drug" (17 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (5 trials), "Vemurafenib" (4 trials), "Cobimetinib" (3 trials), "Ipilimumab" (2 trials) and "Nivolumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Angeles Clinic and Research Institute - W LA Office" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Angeles Clinic and Research Institute - W LA Office". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in The Angeles Clinic and Research Institute - W LA Office, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Angeles Clinic and Research Institute - W LA Office, 8 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".